These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 17278120)
1. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Lambert MP; Shields C; Meadows AT Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120 [TBL] [Abstract][Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [TBL] [Abstract][Full Text] [Related]
4. Assessment of hearing in very young children receiving carboplatin for retinoblastoma. Smits C; Swen SJ; Theo Goverts S; Moll AC; Imhof SM; Schouten-van Meeteren AY Eur J Cancer; 2006 Mar; 42(4):492-500. PubMed ID: 16376542 [TBL] [Abstract][Full Text] [Related]
5. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Turaka K; Shields CL; Meadows AT; Leahey A Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785 [TBL] [Abstract][Full Text] [Related]
6. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802 [TBL] [Abstract][Full Text] [Related]
7. Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Jehanne M; Lumbroso-Le Rouic L; Savignoni A; Aerts I; Mercier G; Bours D; Desjardins L; Doz F Pediatr Blood Cancer; 2009 May; 52(5):637-43. PubMed ID: 19148943 [TBL] [Abstract][Full Text] [Related]
8. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578 [TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [TBL] [Abstract][Full Text] [Related]
11. The success of primary chemotherapy for group D heritable retinoblastoma. Cohen VM; Kingston J; Hungerford JL Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556 [TBL] [Abstract][Full Text] [Related]
12. Preliminary results of primary chemotherapy in retinoblastoma. Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453 [TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and treatment of retinoblastoma in Korea. Chung SE; Sa HS; Koo HH; Yoo KH; Sung KW; Ham DI Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212 [TBL] [Abstract][Full Text] [Related]
14. Carboplatin-associated ototoxicity in children with retinoblastoma. Qaddoumi I; Bass JK; Wu J; Billups CA; Wozniak AW; Merchant TE; Haik BG; Wilson MW; Rodriguez-Galindo C J Clin Oncol; 2012 Apr; 30(10):1034-41. PubMed ID: 22370329 [TBL] [Abstract][Full Text] [Related]
15. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860 [TBL] [Abstract][Full Text] [Related]